Clinical Trial Update: HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating an HPV16 DNA vaccine delivered by electroporation for cervical intraepithelial neoplasia grades II/III is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia Grade Ii
• Cervical Intraepithelial Neoplasia Grade Iii

Drugs mentioned

• HPV DNA vaccine via electroporation

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Human Papillomavirus Type 16, Cervical Intraepithelial Neoplasia Grade II | Phase 1 | Status: RECRUITING